MatriSys Bioscience

MatriSys Bioscience

Signal active

Organization

Contact Information

Overview

MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients.

About

Industries

Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma

Founded

2015

Employees

1-10

Headquarters locations

La Jolla, California, United States, North America

Social

Profile Resume

MatriSys Bioscience headquartered in United States, North America, operates in the Biotechnology, Health Care, Pharmaceutical, Medical, Biopharma sector. The company focuses on Biotechnology and has secured $360.0M in funding across 80 round(s). With a team of 1-10 employees, MatriSys Bioscience is actively contributing to advancements in Biotechnology. Their latest funding round, Convertible Note - MatriSys Bioscience, raised $1.5M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Philippe P. Calais

Philippe P. Calais

President and CEO

imagePlace Mark S. Wilson

Mark S. Wilson

Board Member

imagePlace Richard Gallo

Richard Gallo

Co-Founder and Head

Funding Rounds

Funding rounds

4

Investors

1

Lead Investors

0

Total Funding Amount

$4.5M

Details

1

MatriSys Bioscience has raised a total of $4.5M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2018Seed

Investors

MatriSys Bioscience is funded by 9 investors.

Investor NameLead InvestorFunding RoundPartners
MatriSys Bioscience-FUNDING ROUND - MatriSys Bioscience3.0M
Primer Capital-FUNDING ROUND - Primer Capital3.0M
MatriSys Bioscience-FUNDING ROUND - MatriSys Bioscience1.5M
Tech Coast Angels-FUNDING ROUND - Tech Coast Angels1.5M